Durable Bene fi ts of Cellular Postconditioning : Long-Term Effects of Allogeneic Cardiosphere-Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction

Methods and Results-—Minipigs underwent 1.5-hourmid-left anterior descending balloon occlusion followed by reperfusion andwere randomized to receive intracoronary allo-CDCs or vehicle 30 minutes postreperfusion. Left ventriculography (LVG) demonstrated preserved ejection fraction (EF) and attenuation of LV remodeling in CDC-treated pigs. Pigs underwent cardiac magnetic resonance imaging (MRI) and LVG 1 hour and 8 weeks after therapy to evaluate efficacy. MRI showed improvement of EF and attenuation of LV remodeling immediately after allo-CDC infusion. In addition, allo-CDCs improved regional function and decreased hypertrophy 2 months post-treatment. Histological analysis revealed increased myocardial salvage index, enhanced vascularity, sustained reductions in infarct size/area at risk and scar transmurality, and attenuation of collagen deposition in the infarct zone of allo-CDCtreated pigs at 2 months. Allo-CDCs did not evoke lymphohistiocytic infiltration or systemic humoral memory response. Short-term experiments designed to probe mechanism revealed antiapoptotic effects of allo-CDCs on cardiomyocytes and increases in cytoprotective macrophages, but no increase in overall inflammatory cell infiltration 2 hours after cell therapy.

[1]  E. Marbán,et al.  Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction. , 2015, The Journal of clinical investigation.

[2]  E. Marbán,et al.  Cardiac regeneration validated , 2015, Nature Biotechnology.

[3]  E. Marbán,et al.  Cellular Postconditioning: Allogeneic Cardiosphere-Derived Cells Reduce Infarct Size and Attenuate Microvascular Obstruction When Administered After Reperfusion in Pigs With Acute Myocardial Infarction , 2015, Circulation. Heart failure.

[4]  E. Marbán.  Breakthroughs in cell therapy for heart disease: focus on cardiosphere-derived cells. , 2014, Mayo Clinic proceedings.

[5]  D. Liem,et al.  THY-1 Receptor Expression Differentiates Cardiosphere-Derived Cells with Divergent Cardiogenic Differentiation Potential , 2014, Stem cell reports.

[6]  Katherine C. Wu,et al.  Autologous Mesenchymal Stem Cells Produce Concordant Improvements in Regional Function, Tissue Perfusion, and Fibrotic Burden When Administered to Patients Undergoing Coronary Artery Bypass Grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Sur , 2014, Circulation research.

[7]  A. Bayés‐Genís,et al.  Allogeneic adipose stem cell therapy in acute myocardial infarction , 2014, European journal of clinical investigation.

[8]  E. Marbán,et al.  Validation of Contrast-Enhanced Magnetic Resonance Imaging to Monitor Regenerative Efficacy After Cell Therapy in a Porcine Model of Convalescent Myocardial Infarction , 2013, Circulation.

[9]  S. Gronthos,et al.  Impact of timing and dose of mesenchymal stromal cell therapy in a preclinical model of acute myocardial infarction. , 2013, Journal of cardiac failure.

[10]  E. Marbán,et al.  Allogeneic cardiospheres safely boost cardiac function and attenuate adverse remodeling after myocardial infarction in immunologically mismatched rat strains. , 2013, Journal of the American College of Cardiology.

[11]  E. Marbán,et al.  Heart to heart: cardiospheres for myocardial regeneration. , 2012, Heart rhythm.

[12]  T. Miura,et al.  Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning , 2012, Cardiovascular Diabetology.

[13]  H. Bøtker,et al.  Measuring myocardial salvage. , 2012, Cardiovascular research.

[14]  E. Marbán,et al.  Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. , 2012, Journal of the American College of Cardiology.

[15]  E. Marbán,et al.  Safety and Efficacy of Allogeneic Cell Therapy in Infarcted Rats Transplanted With Mismatched Cardiosphere-Derived Cells , 2012, Circulation.

[16]  C. Berry,et al.  Bright-Blood T2-Weighted MRI Has Higher Diagnostic Accuracy Than Dark-Blood Short Tau Inversion Recovery MRI for Detection of Acute Myocardial Infarction and for Assessment of the Ischemic Area at Risk and Myocardial Salvage , 2011, Circulation. Cardiovascular imaging.

[17]  P. Pattany,et al.  Bone Marrow Mesenchymal Stem Cells Stimulate Cardiac Stem Cell Proliferation and Differentiation , 2010, Circulation research.

[18]  J. Lunney,et al.  Molecular characterization of swine leucocyte antigen class II genes in outbred pig populations. , 2009, Animal genetics.

[19]  A. Boyle,et al.  Mesenchymal stem cell therapy for cardiac repair. , 2010, Methods in molecular biology.

[20]  E. Marbán,et al.  Validation of the Cardiosphere Method to Culture Cardiac Progenitor Cells from Myocardial Tissue , 2009, PloS one.

[21]  C. Lavie,et al.  Clinical impact of left ventricular hypertrophy and implications for regression. , 2009, Progress in cardiovascular diseases.

[22]  GunnarEngström,et al.  Leukocyte Count and Incidence of Hospitalizations Due to Heart Failure , 2009 .

[23]  J. Lunney,et al.  Molecular characterization of swine leucocyte antigen class I genes in outbred pig populations. , 2009, Animal genetics.

[24]  J. Schulz-Menger,et al.  The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. , 2008, Journal of the American College of Cardiology.

[25]  P. Libby,et al.  The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions , 2007, The Journal of experimental medicine.

[26]  Yao‐Hua Song,et al.  Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. , 2007, European heart journal.

[27]  Ryuji Ohtani,et al.  Relation between neutrophil counts on admission, microvascular injury, and left ventricular functional recovery in patients with an anterior wall first acute myocardial infarction treated with primary coronary angioplasty. , 2007, The American journal of cardiology.

[28]  E. Marbán,et al.  Regenerative Potential of Cardiosphere-Derived Cells Expanded From Percutaneous Endomyocardial Biopsy Specimens , 2007, Circulation.

[29]  M. Swindle,et al.  Swine in the laboratory: surgery, anesthesia, imaging, and experimental techniques , 2007 .

[30]  N. Frangogiannis.  Targeting the inflammatory response in healing myocardial infarcts. , 2006, Current medicinal chemistry.

[31]  R. F. Hoyt,et al.  Cardiac magnetic resonance imaging , 2004, Postgraduate Medical Journal.

[32]  Silviu Itescu,et al.  Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[33]  R. Kloner,et al.  Cardiac protection during acute myocardial infarction: where do we stand in 2004? , 2004, Journal of the American College of Cardiology.

[34]  J. Schulz-Menger,et al.  Delayed Enhancement and T2-Weighted Cardiovascular Magnetic Resonance Imaging Differentiate Acute From Chronic Myocardial Infarction , 2004, Circulation.

[35]  S. Ishikawa,et al.  Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling. , 2002, Journal of the American College of Cardiology.

[36]  E. Braunwald,et al.  Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris , 2001 .

[37]  E R McVeigh,et al.  Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. , 1998, Circulation.

[38]  S. Ogawa,et al.  C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. , 1997, Circulation.

[39]  Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. , 1989, The New England journal of medicine.